AIR vs LQDA Comparison

AAR Corp offers a broad line of products and services to commercial and government aerospace customers and operates internationally. It is a diversified provider of services and products to the commercial aviation and government and defense markets, serving aircraft fleet operators, original equipment manufacturers, independent service providers, and domestic and foreign military customers. It operates through the Parts Supply, Repair, Engineering and Software, Government Solutions, and Legacy Commercial Programs segments. The Parts Supply segment mainly consists of new parts distribution and sales of used serviceable material, including aircraft, engine, and airframe parts and components (USM), and generates the maximum revenue. It generates the maximum revenue from North America.

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.